ACE inhibitors can raise
potassium levels. Hyperkalaemia is therefore a possibility if
potassium supplements or potassium-containing salt substitutes are given, particularly in those patients where other risk factors are present, such as decreased
renal function.
Monitor
potassium levels, adjusting supplementation as necessary.